Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.75 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.75 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4426573 | 1.00 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL300415 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL5275106 | 1.00 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL132413 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL5966158 | 1.00 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL1896740 | 1.00 | CA5A (0.75) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL23496267 | 0.94 | CA5A (0.67) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL10506315 | 0.94 | CA5A (0.67) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL1716331 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL3434323 | 0.94 | CA5A (0.67) | CA5ACA5BTSHRCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260024793-A1 | MEMBRANE ELECTRODE ASSEMBLY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20260024779-A1 | MEMBRANE ELECTRODE ASSEMBLY AND FUEL CELL | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20260024780-A1 | MEMBRANE ELECTRODE ASSEMBLY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20250183342-A1 | LIQUID COMPOSITION, POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY AND POLYMER ELECTROLYTE FUEL CELL | AGC Inc. (JP) | 2025-06-05 | — | — | US | disclosed |
| US-12261335-B2 | Liquid composition, polymer electrolyte membrane, membrane electrode assembly and polymer electrolyte fuel cell | AGC Inc. (JP) | 2025-03-25 | — | — | US | disclosed |
| EP-3719904-B1 | POLYMER ELECTROLYTE MEMBRANE, METHOD FOR MANUFACTURING SAME, AND MEMBRANE ELECTRODE ASSEMBLY COMPRISING SAME | KOLON INC (KR) | 2025-02-26 | — | — | EP | disclosed |
| US-20250015330-A1 | MEMBRANE ELECTRODE ASSEMBLY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2025-01-09 | — | — | US | disclosed |
| US-20240154132-A1 | MEMBRANE ELECTRODE ASSEMBLY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2024-05-09 | — | — | US | disclosed |
| US-20240128469-A1 | MEMBRANE ELECTRODE ASSEMBLY | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2024-04-18 | — | — | US | disclosed |
| US-11898018-B2 | Liquid composition, polymer electrolyte membrane, membrane electrode assembly and polymer electrolyte fuel cell | AGC Inc. (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20040127754-A1 | Liquid phase oxygenation reaction using tungsten species | NIPPON SHOKUBAI CO., LTD. | 2004-07-01 | — | — | US | disclosed |
| US-20040122243-A1 | Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds | SHOWA DENKO K.K. (JP) | 2004-06-24 | — | — | US | disclosed |
| US-20040092757-A1 | Crystalline MWW-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. | 2004-05-13 | — | — | US | disclosed |
| EP-1398080-A1 | Liquid phase oxygenation reaction using tungsten species | Nippon Shokubai Co., Ltd. (JP) | 2004-03-17 | — | — | EP | disclosed |
| US-20040034258-A1 | Crystalline MWW-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. | 2004-02-19 | — | — | US | disclosed |
| EP-1324948-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE, ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | Showa Denko K.K. (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-20030055281-A1 | Palladium-based catalysts | MORI YOSHIHIKO (JP) | 2003-03-20 | — | — | US | disclosed |
| US-6528679-B1 | Process for producing phenyl esters using palladium-based catalysts | TOSOH CORPORATION (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20030040649-A1 | Crystalline mww-type titanosilicate catalyst for producing oxidized compound, production process for the catalyst, and process for producing oxidized compound by using the catalyst | SHOWA DENKO K.K. (JP) | 2003-02-27 | — | — | US | disclosed |
| WO-2002028774-A2 | CRYSTALLINE MWW-TYPE TITANOSILICATE , ITS PREPARATION AND USE THEREOF FOR PRODUCING EPOXIDES | SHOWA DENKO K. K. (JP) | 2002-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260024793-A1 | MEMBRANE ELECTRODE ASSEMBLY | LNPK, VAMP8, EMC2 | CA5A 257/4885CA5B 546/4885TSHR 2043/4885 |
| US-20260024779-A1 | MEMBRANE ELECTRODE ASSEMBLY AND FUEL CELL | LNPK, CA9, CA12 | CA5A 78/4885CA5B 168/4885TSHR 1902/4885 |
| US-20260024780-A1 | MEMBRANE ELECTRODE ASSEMBLY | KCNJ8, KCNN4, KCNN2 | CA5A 189/4885CA5B 279/4885TSHR 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.